10X Capital
10X Capital Podcast
The 10X Capital podcast interviews the world's premier institutional investors to deliver insights on how they manage their capital. Interview topics include investment decision frameworks, capital allocation strategies, GP/LP relationships and many more.
Be sure to visit the podcast's website and support the creator: 10xcapitalpodcast.com
Author
10X Capital
Category
Podcast website
Latest episode
Dec 3, 2024
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
E42: 6 Hard Questions You Should Ask LPs When Raising Your Venture Capital Fund with Katie Riester 15.02.2024 31:20
Katie Riester, Managing Director at Felicis sits down with David Weisburd to discuss venture capital fund strategies, building relationships with GPs, and the math behind venture capital. They discuss the importance of clear communication with LPs, common red flags, and advice for new LPs.
E41: How Everyday Investors Can Access Blackstone, Apollo, and KKR? 13.02.2024 32:35
Michael Sidgmore of Broadhaven sits down with David Weisburd to talk about the growth of the wealth channel and its link to private equity. They discuss iCapital's role in the venture world, access issues for family offices, and the strategies of Broadhaven Ventures. The conversation also covers GP stakes, the future of emerging managers, and the potential of IRA funds for venture capital and real...
E40: Dave McClure on Delivering a 60x & 40x fund and Founding 500 Startups 08.02.2024 47:45
Dave McClure sits down with David Weisburd to discuss his journey into venture capital, including luck, his investment strategy, and the challenges he faced breaking into the industry. He provides an analysis on his two 40x+ funds, 500 Startups, and the misalignment between LPs and GPs.
E39: Guy Perelmuter on Generating Alpha in Deeptech 06.02.2024 41:16
Guy Perelmuter of GRIDS Capital sits down with David Weisburd to discuss his investment strategy, the unique portfolio construction of deep tech companies, and the potential of DeepTech. They delve into the paradox of AI, its impacts on the labor force, and discuss the ideal GP relationship and transparency. They also touch on LP value-add and the importance of overcommunication.
E38: Carrie Thome & Grady Buchanan of NVNG on How to Raise Capital from Corporate LPs 01.02.2024 36:15
Grady Buchanan and Carrie Thome join David Weisburd to discuss their perspectives on venture capital and strategic investment, drawing from Carrie's 18 years at WARF. They explore the unique model of WARF, the transition from hedge funds to venture capital, and the challenges of managing liquidity. The conversation delves into the all-weather investing approach, founding NVNG, and raising a fund d...
E37: Errik Anderson on Co-Founding 20 Biotech Startups Cumulatively Worth $10B+ 30.01.2024 1:01:24
Errik Anderson sits down with David Weisburd to discuss Pro-noia, the potential of the biotech industry, and the 82VS Seed Fund investment approach. They discuss practicing Pro-noia, the value of building a portfolio of relationships, and the idea of a forever company.
E36: Masterclass on Portfolio Construction with Anubhav Srivastava, CEO of Tactyc 26.01.2024 23:43
Anubhav Srivastava, CEO of Tactyc, sits down with David Weisburd to discuss iterative portfolio construction, portfolio size impact, fund recycling and check size, reserve strategies, and follow-on investments. They also explore the future of Tactyc and lessons from clients.
E35: Ben Gallacher of Cannonball on "Value per Dollar Invested" and How it Predicts Fund Performance 23.01.2024 42:26
Ben Gallacher sits down with David Weisburd to discuss venture capital, his journey as an LP, and the challenges emerging managers face. They discuss check sizes, diligence processes, and the impact of a GP leaving during an investment life cycle. They also cover the role of CFO/COO in GP operations and the importance of supporting emerging managers.
E34: Aakar Vachhani of Fairview on What The Top 1% of GP’s Share in Common 18.01.2024 1:00:22
Aakar Vachhani sits down with David Weisburd to discuss the role of data in venture capital, Fairview's unique structure, and their co-investment program. They also delve into the discipline of making investment decisions, the advantages of a fund of funds, and the importance of team cohesion in VC firms. Vachhani also shares best practices for data rooms and advice for LPs as Fairview celebrates...
E33: Charmel Maynard, CIO of University of Miami on Building a Venture Book 16.01.2024 34:56
Charmel Maynard, CIO of University of Miami, sits down with David Weisburd to discuss asset allocation, diversification strategies, and the process of assessing venture funds. The conversation also covers unique VC challenges, tracking emerging managers, and the importance of diversity in asset management.
E32: Ashby Monk, Stanford Professor on How to Become a Billionaire in Private Equity 11.01.2024 56:30
Ashby Monk, Executive and Research Director at Stanford sits down with David Weisburd to discuss the role and operation of asset owners like pension funds, endowments, and more. They delve into compensation in these fields, the state of pension funds in the US, and their impact on private equity.
E31: David Friedberg on How To Build a Billion Dollar Startup 09.01.2024 48:29
David Friedberg sits down with David Weisburd to discuss the role of concentrated capital, venture capital's future, and the impact of capital saturation. Friedberg shares his experience joining Ohalo, the evolution of investment strategy, and the transition from VC to operator.
E30: Alan Feld, Co-Founder of Vintage Investment Partners on How to Handle Succession in VC 04.01.2024 48:03
Alan Feld sits down with David Weisburd to talk about his experience founding Vintage, the significance of product-market fit in VC, and how Vintage has thrived over two decades. They discuss the impact of personal history on investment decisions, building an enduring VC firm culture, and engaging with General Partners. They also touch on successful GP cultures, investment allocation, and VC-LP re...
E29: Lo Toney, Plexo Capital on How He Raised Capital from Google, the Ford Foundation, Mass Mutual 02.01.2024 55:23
David Weisburd interviews Lo Toney about his transition from angel investor to fund manager, his role at Plexo Capital, and his approach to working with founders. They discuss the importance of patience in early-stage investments, the diligence process for managers, and the strategy behind selecting LPs.
E28: Roland Reynold, Industry Ventures on Investing $7 Billion into Startups & Venture Funds 14.12.2023 45:14
Roland Reynolds, Senior Managing Director at Industry Ventures, sits down with David Weisburd to discuss being one of the first investors in emerging managers and how he uses secondaries to drive alpha.
E27: Fernando Pontaza of Invariantes on Why 25% IRR is the Gold Standard in Venture 12.12.2023 34:49
Fernando Pontaza, Co-Founder of Invariantes sits down with David Weisburd to discuss setting up the first Guatemalan Venture Capital Fund and why he targets a 25% IRR.
E26: Winter Mead of Coolwater on Building the YC for GPs 08.12.2023 50:29
Winter Mead, Founder and CEO of Coolwater Capital sits down with David Weisburd to discuss the importance of emerging managers and how Coolwater Capital is building the YC for GPs.
E25: Jeff Galvin, CEO of Addimmune on Finding a Cure for HIV 06.12.2023 34:14
Jeff Galvin, CEO of Addimmune, sits down with David Weisburd to discuss cell and gene therapy, and how Addimmune is working on a functional solution for HIV.
E24: Joshua Berkowitz of Berkocorp on Why LP's Should Care about IRR% not TVPI 30.11.2023 1:02:48
Joshua Berkowitz of Berkocorp, sits down with David Weisburd to discuss investing in venture capital as a family office and why all investors should care about IRR (and not TVPI).
E23: How Israel’s Largest Hospital Delivers Care to Palestinians through “Peace Through Health" 28.11.2023 26:31
Brian Abrahams, CEO of American Friends of Sheba Medical Center, sits down with David Weisburd to discuss its “Peace through Health Initiative” and how the hospital has been helping Israeli and Palestinian citizens during the current conflict.
E22: Alex Edelson of Slipstream on The 4 Sources of Alpha for Emerging Managers 21.11.2023 58:44
Alex Edelson of Slipstream Investors, sits down with David Weisburd and Erik Torenberg to discuss the four sources of alpha for emerging managers (Sourcing, Picking, Winning, and Value-Add).
E21: Jake Paul and Joey Levy of Betr on How to Build a $100 Billion Company 16.11.2023 33:57
Jake Paul and Joey Levy, co-founder of Betr, sit down with David Weisburd to discuss the sports betting industry and how to build a $100 billion company.
E20: James Heath, dara5 on How Family Offices Access Top Venture Funds 14.11.2023 54:14
James Heath, Investment Principal at dara5, sits down with David Weisburd to discuss early stage venture.
E19: Raja Doddala, Head of VC at Churchill ($47 Billion AUM) on How LP’s Should Diligence GP’s 09.11.2023 38:47
Raja Doddala, Head of VC at Churchill Asset Management, sits down with David Weisburd to discuss how Churchill diligences managers, and the importance of integrity in a GP.
E18: Avlok Kohli, CEO of AngelList on How He Turned AngelList into a $4 Billion Dollar Company 07.11.2023 52:19
Avlok Kohli, CEO of AngelList sits down with David Weisburd and Erik Torenberg to discuss how he grew AngelList into a $4B dollar company.
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.